Center watch clinical trialsBelow is clinical trial information for Nucryst's atopic dermatitis drug (The giveaway is "Not have a sensitivity or allergy to silver and/or cocoa butter"). I do not believe that this information is still here from the completed Phase II. So, am I wrong about this or have we started enrolling for phase III?
https://www.centerwatch.com/patient/studies/stu54162.html
Trial Information
Summary: Atopic Dermatitis- Mild to Moderate for Adults
Sadick Research Group, LLC is currently looking for subjects to participate in a research study for individuals with Atopic Dermatitis (Eczema).
This is a 8-week, double-blind study. Study drug and procedures will be made available to you at no cost. Compensation will be provided for travel expenses.
To qualify you must:
* Be between the ages of 18 and 65
* Have been diagnosed with atopic dermatitis
* Not be pregnant or breastfeeding
* Not have a sensitivity or allergy to silver and/or cocoa butter
If you decide to participate in this study it is possible that you could be randomly assigned to receive placebo (a substance that looks like the study drug but does not contain active ingredients), not the active study drug that this research study is evaluating.
Contact:
Dr. Neil Sadick
Biomedical Research Alliance of New York
Sadick Research Group, LLC
772 Park Avenue
New York, NY 10021
Telephone: 212-772-7242
Email: nssderm@sadickdermatology.com
Profile Page: Biomedical Research Alliance of New York, New York, NY